Walleye Capital LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$3,002,000
-12.0%
44,084
-58.7%
0.06%
-39.4%
Q2 2022$3,412,000
+47.9%
106,796
+60.4%
0.09%
+51.6%
Q1 2022$2,307,000
+1019.9%
66,599
+1298.6%
0.06%
+342.9%
Q4 2020$206,000
-88.1%
4,762
-78.2%
0.01%
-87.6%
Q4 2019$1,733,000
-74.9%
21,800
-84.7%
0.11%
-72.5%
Q3 2019$6,895,000
+340.0%
142,100
+376.8%
0.41%
+139.0%
Q2 2019$1,567,000
-9.7%
29,800
-9.1%
0.17%
-39.9%
Q1 2019$1,736,00032,8000.29%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders